Author(s): Navdeep Singh, Shivi Sondhi, Sanyam Sharma, Dheeraj Singh, Vishal Koundal, Kamya Goyal, Shammy Jindal

Email(s): shammyjindal@gmail.com

DOI: 10.52711/0974-360X.2021.00973   

Address: Navdeep Singh1, Shivi Sondhi1, Sanyam Sharma2, Dheeraj Singh2, Vishal Koundal2, Kamya Goyal2, Shammy Jindal1*
1Department of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, Himachal Pradesh, India – 176031.
2Department of Pharmaceutical Chemistry and Analysis, Laureate Institute of Pharmacy, Kathog, Himachal Pradesh India – 176031.
*Corresponding Author

Published In:   Volume - 14,      Issue - 10,     Year - 2021


ABSTRACT:
Nanoparticles offer novel openings for the management of dermal diseases. The skin being a largest organ of the body poses a barrier to all the delivery system including nanoparticles to permeate deep in to the cells or tissues. This barrier was ruptured in case of skin trauma or injury and also in the case of skin cancer. This conditions of the skin allowed the nanoparticles to permeate through the skin for the treatment of cancer. Worldwide research is going in to the formulation and development of the Nano carrier for the dermal delivery through the skin. But the little or negligible technology transfer occur from the R&D to Industry for the treatment of skin cancer using nanoparticles. The main aim of review is to discuss about the basic fundamentals of cancer with relate to dermal delivery of drug through Nanoparticles. The nanotechnologies for dermal delivery of drugs were explained for their effective tool for skin cancer. In this review types of skin cancer with various nanotechnologies were discussed along with pathology of disease and various therapies used. Further we had discussed challenges in developing the nanoparticles for the treatment in the skin cancer therapy. Finally various therapies like Chemotherapies, Immunotherapy, Gene therapy, Nano carriers combined with physical methods and Laser irradiation therapies were summarized.


Cite this article:
Navdeep Singh, Shivi Sondhi, Sanyam Sharma, Dheeraj Singh, Vishal Koundal, Kamya Goyal, Shammy Jindal. Treatment of Skin Cancer by Topical Drug Delivery of Nanoparticles: A Review. Research Journal of Pharmacy and Technology 2021; 14(10):5589-8. doi: 10.52711/0974-360X.2021.00973

Cite(Electronic):
Navdeep Singh, Shivi Sondhi, Sanyam Sharma, Dheeraj Singh, Vishal Koundal, Kamya Goyal, Shammy Jindal. Treatment of Skin Cancer by Topical Drug Delivery of Nanoparticles: A Review. Research Journal of Pharmacy and Technology 2021; 14(10):5589-8. doi: 10.52711/0974-360X.2021.00973   Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-10-91


REFERENCES:
1.    Estava A, Kuprel B, Novoa RA. Dermatologist level classification of skin cancer with deep neural networks [J]. Nature. 2017; 542:115.
2.    Victor A, Ghalib MR. Detection of Skin Cancer Cells-A Review. Research Journal of Pharmacy & Technology. 2017;10(11): 4093-8.
3.    Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA dermatology. 2015;151(10): 1081-6.
4.    Sreelatha T, Subramanyam MV, Prasad MN. A Survey work on Early Detection methods of Melanoma Skin Cancer. Research Journal of Pharmacy & Technology. 2019;12(5): 2589-96.
5.    Palmer BC, DeLouise LA. Nanoparticle-enabled transdermal drug delivery systems for enhanced dose control & tissue targeting. Molecules. 2016; 21(12): 1719.
6.    Micali G, Lacarrubba F, Nasca MR, Ferraro S, Schwartz RA. Topical pharmacotherapy for skin cancer: part II. Clinical applications. Journal of the American Academy of Dermatology. 2014; 70(6): 979-e1.
7.    Birajdar GO, Kadam VS, Chintale AG, Halle PD, Nabde MK, Maske KS. A Comprehensive review on nanotechnology. Research Journal of Pharmacy & Technology. 2013;6(5): 486-95.
8.    Sparreboom A, Scripture CD, Trieu V, Williams PJ, De T, Yang A, Beals B, Figg WD, Hawkins M, Desai N. Comparative preclinical & clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) & paclitaxel formulated in Cremophor (Taxol). Clinical cancer research. 2005; 11(11): 4136-43.
9.    Zhang L, Zhang N. How nanotechnology can enhance docetaxel therapy. International journal of nanomedicine. 2013;8: 2927.
10.    Anselmo AC, Mitragotri S. Nanoparticles in the clinic: An update. Bioengineering & Translational Medicine. 2019;4(3):e10143.
11.    Jana U, Pal S, Mohanta GP, Manna PK, Manavalan R. Nanoparticles: A Potential Approach for Drug Delivery. Research Journal of Pharmacy & Technology. 2011;4(7):1016-9.
12.    Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration & distribution of polymeric nanoparticles. Journal of Controlled Release. 2004;99(1):53-62.
13.    Fang CL, Aljuffali IA, Li YC, Fang JY. Delivery & targeting of nanoparticles into hair follicles. Therapeutic delivery. 2014;5(9):991-1006.
14.    Simões MF, Sousa JS, Pais AC. Skin cancer & new treatment perspectives: A review. Cancer letters. 2015;357(1):8-42.
15.    Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds & drugs. Experimental Dermatology: Viewpoint. 2000;9(3):165-9.
16.    Ishii H. Drugs in Topical Formulations. InSkin Permeation & Disposition of Therapeutic & Cosmeceutical Compounds 2017 (pp. 263-271). Springer, Tokyo.
17.    Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration & distribution of polymeric nanoparticles. Journal of Controlled Release. 2004;99(1):53-62.
18.    Dayan N. Pathways for skin penetration. Cosmetics & toiletries. 2005;120(6):67-76.
19.    Tagami H, Natsume N, Aoshima T, Inoue F, Suehisa S, Yamada M. Analysis of transepidermal leukocyte chemotaxis in experimental dermatophytosis in guinea pigs. Archives of Dermatological Research. 1982;273(3-4):205-17.
20.    Kurtz SL, Lawson LB. Determination of permeation pathways of hydrophilic or hydrophobic dyes through the mammary papilla. International journal of pharmaceutics. 2018;545(1-2):10-8.
21.    Dhamecha DL, Rathi AA, Saifee M, Lahoti SR, Dehghan MH. Drug vehicle based approaches of penetration enhancement. Int J Pharm Pharm Sci. 2009;1(1):24-46.
22.    Pawar PM, Solanki KP, M&ali VA. Recent Advancements in Transdermal Drug Delivery System. International Journal of Pharmaceutical & Clinical Research. 2018;10(3):65-73.
23.    Schulman JM, Fisher DE. Indoor UV tanning & skin cancer: health risks & opportunities. Current opinion in oncology. 2009;21(2):144.
24.    Zhang M, Qureshi AA, Geller AC, Frazier L, Hunter DJ, Han J. Use of tanning beds & incidence of skin cancer. Journal of Clinical Oncology. 2012;30(14):1588.
25.    Cantor D. Introduction: cancer control & prevention in the twentieth century. Bulletin of the History of Medicine. 2007;81(1):1-38.
26.    Ojaswi G, Divya N, Digna P. Melanoma & its Drug Targets. Research Journal of Pharmacy & Technology. 2016;9(5):562-70.
27.    Apalla Z, Nashan D, Weller RB, Castellsagué X. Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, & therapeutic approaches. Dermatology & therapy. 2017;7(1):5-19.
28.    Stockfleth E, Ferr&iz C, Grob JJ, Leigh I, Pehamberger H, Kerl H. Development of a treatment algorithm for actinic keratoses: a European Consensus. European Journal of Dermatology. 2008;18(6):651-9.
29.    Padilla RS, Sebastian S, Jiang Z, Nindl I, Larson R. Gene expression patterns of normal human skin, actinic keratosis, & squamous cell carcinoma: a spectrum of disease progression. Archives of dermatology. 2010;146(3):288-93.
30.    Franceschi S, Levi F, R&imbison L, La Vecchia C. Site distribution of different types of skin cancer: new aetiological clues. International journal of cancer. 1996;67(1):24-8.
31.    Siller G, Gebauer K, Welburn P, Katsamas J, Ogbourne SM. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a r&omized, double‐blind, vehicle‐controlled, multicentre, phase IIa study. Australasian Journal of Dermatology. 2009;50(1):16-22.
32.    Amini S, Viera MH, Valins W, Berman B. Nonsurgical innovations in the treatment of nonmelanoma skin cancer. The Journal of clinical & aesthetic dermatology. 2010;3(6):20.
33.    Goldenberg G, Perl M. Actinic keratosis: update on field therapy. The Journal of clinical & aesthetic dermatology. 2014;7(10):28.
34.    Garcia‐Serra A, Hinerman RW, Mendenhall WM, Amdur RJ, Morris CG, Williams LS, Mancuso AA. Carcinoma of the skin with perineural invasion. Head & Neck: Journal for the Sciences & Specialties of the Head & Neck. 2003;25(12):1027-33.
35.    Kimyai-Asadi A, Goldberg LH, Peterson SR, Silapint S, Jih MH. The incidence of major complications from Mohs micrographic surgery performed in office-based & hospital-based settings. Journal of the American Academy of Dermatology. 2005;53(4):628-34.
36.    Bray FN, Simmons BJ, Wolfson AH, Nouri K. Acute & chronic cutaneous reactions to ionizing radiation therapy. Dermatology & therapy. 2016;6(2):185-206.
37.    Abirla M, Rajakumari K. Nanotherapy for Cancer–A Review. Research Journal of Pharmacy & Technology. 2020;13(3):1575-9.
38.    Roopa M, Mohan A. Novel Approaches in Nanoparticulate Drug Delivery System to Overcome Human Immunodeficiency Virus. Research Journal of Pharmacy & Technology. 2019;12(7):3189-96.
39.    Haque T, Rahman KM, Thurston DE, Hadgraft J, Lane ME. Topical therapies for skin cancer & actinic keratosis. European Journal of Pharmaceutical Sciences. 2015;77:279-89.
40.    Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. The lancet. 2010;375(9715):673-85.
41.    McGillis ST, Fein H. Topical treatment strategies for non-melanoma skin cancer & precursor lesions. In Seminars in cutaneous medicine & surgery 2004 Sep 1 (Vol. 23, No. 3, pp. 174-183).
42.    Micali G, Lacarrubba F, Nasca MR, Ferraro S, Schwartz RA. Topical pharmacotherapy for skin cancer: part II. Clinical applications. Journal of the American Academy of Dermatology. 2014;70(6):979-e1.
43.    Kolenyak dos Santos F, Helena Oyafuso M, Priscila Kiill C, Palmira Daflon-Gremiao M, Chorilli M. Nanotechnology-based drug delivery systems for treatment of hyperproliferative skin diseases-a review. Current Nanoscience. 2013;9(1):159-67.
44.    Cevc G, Vierl U. Nanotechnology & the transdermal route: A state of the art review & critical appraisal. Journal of controlled release. 2010;141(3):277-99.
45.    Liu M, Li M, Sun S, Li B, Du D, Sun J, Cao F, Li H, Jia F, Wang T, Chang N. The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy. Biomaterials. 2014;35(11):3697-707.
46.    Sankar C, Muthukumar S, Arulkumaran G, Shalini S, Sundaraganapathy R. Formulation & Characterization of Liposomes containing Clindamycin & Green tea for Anti Acne. Research Journal of Pharmacy & Technology. 2019;12(12):5977-84.
47.    Vora B, Khopade AJ, Jain NK. Proniosome based transdermal delivery of levonorgestrel for effective contraception. Journal of controlled release. 1998;54(2):149-65.
48.    Rao NN, Chowdary P, Divya Y, Laksmi T, Latha K, Sirisha P. Niosomes: A Vesicular Drug Delivery System. Research Journal of Pharmacy & Technology. 2018;11(8):3731-6.
49.    Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients & hydration force. Biochimica et Biophysica Acta-Biomembranes. 1992;1104(1):226-32.
50.    Madhumitha V, Sangeetha S. Transfersomes: A Novel Vesicular Drug Delivery System for Enhanced Permeation through Skin. Research Journal of Pharmacy & Technology. 2020;13(5):2493-501.
51.    Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes—novel vesicular carriers for enhanced delivery: characterization & skin penetration properties. Journal of controlled release. 2000;65(3):403-18.
52.    Maxwell A, Priya S. Nanosized Ethosomes-A Promising Vesicular Drug Carrier for Transdermal Drug Delivery. Research Journal of Pharmacy & Technology. 2019;12(2):876-80.
53.    Godin B, Touitou E. Ethosomes: new prospects in transdermal delivery. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2003;20(1).
54.    Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization & in vitro/in vivo evaluation. Colloids & surfaces B: biointerfaces. 2012;92:299-304.
55.    Jondhalekar TM, Aher SS, Saudagar RB. Transethosome: Novel vesicular carrier for enhanced transdermal drug delivery system. Research Journal of Pharmacy & Technology. 2017;10(6):1816-9.
56.    Reddy SH, Umashankar MS, Damodharan N. Formulation, Characterization & Applications on Solid Lipid Nanoparticles-A Review. Research Journal of Pharmacy & Technology. 2018;11(12):5691-700.
57.    Sachin J, Gupta NV. Solid lipid nanoparticles–preparation, applications, characterization, uses in various cancer therapies: a review. Research Journal of Pharmacy & Technology. 2013;6(8):825-37.
58.    H Muller R, Shegokar R, M Keck C. 20 years of lipid nanoparticles (SLN & NLC): present state of development & industrial applications. Current drug discovery technologies. 2011;8(3):207-27.
59.    Bornare AS, Saudagar RB. Nanostructured Lipid Carrier (NLC): A Modern Approach for Transdermal Drug Delivery. Research Journal of Pharmacy & Technology. 2017;10(8):2784-92.
60.    Chen YC, Liu DZ, Liu JJ, Chang TW, Ho HO, Sheu MT. Development of terbinafine solid lipid nanoparticles as a topical delivery system. International Journal of Nanomedicine. 2012;7:4409.
61.    Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Advanced drug delivery reviews. 2007;59(6):522-30.
62.    Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Advanced drug delivery reviews. 2004;56(9):1257-72.
63.    Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. International journal of pharmaceutics. 2002;238(1-2):241-5.
64.    Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharmaceutical research. 2007;24(1):1.
65.    Prabhakar C, Krishna KB. A Review on Polymeric Nanoparticles. Research Journal of Pharmacy & Technology. 2011;4(4):496-8.
66.    Hasanovic A, Zehl M, Reznicek G, Valenta C. Chitosan‐tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability. Journal of Pharmacy & Pharmacology. 2009;61(12):1609-16.
67.    Pelegrino MT, Weller RB, Chen X, Bernardes JS, Seabra AB. Chitosan nanoparticles for nitric oxide delivery in human skin. MedChemComm. 2017;8(4):713-9.
68.    Sun L, Liu Z, Wang L, Cun D, Tong HH, Yan R, Chen X, Wang R, Zheng Y. Enhanced topical penetration, system exposure & anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel. Journal of Controlled Release. 2017;254:44-54.
69.    Syed IA, Rao YM. Dendrimers based drug delivery systems. Research Journal of Pharmacy & Technology. 2012;5(3):307-16.
70.    Venuganti VV, Perumal OP. Poly (amidoamine) dendrimers as skin penetration enhancers: influence of charge, generation, & concentration. Journal of pharmaceutical sciences. 2009;98(7):2345-56.
71.    Kalaiselvi S, Manimaran V, Damodharan N. Nanoparticle as a powerful tool to penetrate the Blood-brain barrier in the treatment of Neurodegenerative disease: Focus on recent advances. Research Journal of Pharmacy & Technology. 2020;13(5):2135-43.
72.    Witting M, Molina M, Obst K, Plank R, Eckl KM, Hennies HC, Calderón M, Frieß W, Hedtrich S. Thermosensitive dendritic polyglycerol-based nanogels for cutaneous delivery of biomacromolecules. Nanomedicine: Nanotechnology, Biology & Medicine. 2015;11(5):1179-87.
73.    W. Liu, D. Sun, C. Li, Q. Liu, J. Xu, Formation & stability of paraffin oil-in-waternano-emulsions prepared by the emulsion inversion point method, J. Colloid Inter-face Sci. 303 (2006) 557–563.
74.    Saudagar RB, Vaishnav S. Pharmaceutical Nano emulsion as a Rational Carrier for Drug Delivery. Research Journal of Pharmacy & Technology. 2016;9(3):298-304.
75.    Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ. Nano-emulsions. Current opinion in colloid & interface science. 2005;10(3-4):102-10.
76.    Verreck G, Chun I, Rosenblatt J, Peeters J, Van Dijck A, Mensch J, Noppe M, Brewster ME. Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer. Journal of controlled release. 2003;92(3):349-60.
77.    Choudhary S, Dharashivkar S, Mahajan C, Gaikwad M. Formulation & Evaluation of Nano-fiber-based Transdermal patch of Cephalexin. Research Journal of Pharmacy & Technology. 2020;13(6):2787-91.
78.    Mohammed YH, Holmes A, Haridass IN, Sanchez WY, Studier H, Grice JE, Benson HA, Roberts MS. Support for the safe use of zinc oxide nanoparticle sunscreens: lack of skin penetration or cellular toxicity after repeated application in volunteers. Journal of Investigative Dermatology. 2019;139(2):308-15.
79.    Devi GK, Suruthi P, Veera kumar R, Vinoth S, Subbaiya R, Chozhavendhan S. A review on metallic gold & silver nanoparticles. Research Journal of Pharmacy & Technology. 2019;12(2):935-43.
80.    Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ. Functional differentiation & alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development. 1989;105(2):223-35.
81.    Wilhelm S, Bensen RC, Kothapalli NR, Burgett AW, Merrifield R, Stephan C. Quantification of Gold Nanoparticle Uptake into Cancer Cells using Single Cell ICP-MS. PerkinElmer Appl. Note. 2018.
82.    Desai N. Challenges in development of nanoparticle-based therapeutics. The AAPS journal. 2012;14(2):282-95.
83.    Suhesti TS, Fudholi A, Martien R, Martono S. Pharmaceutical nanoparticle technologies: An approach to improve drug solubility & dissolution rate of Piroxicam. Research Journal of Pharmacy & Technology. 2017;10(4):968-74.
84.    Hasan MK, Ghareeb MM, Mate BF, Aga QA. Clinical adverse effects of Chemotherapy protocolusing 6-Mercaptopurine in Iraqi patients with Acute Lymphocytic Leukemia during Maintenance Phase. Research Journal of Pharmacy & Technology. 2019;12(12):5757-64.
85.    Krishnan PR, Siva kumar R. Nanotechnology: Modern Formulation & Evaluation Techniques-An Overview. Research Journal of Pharmacy & Technology. 2019;12(8):4039-44.
86.    Amasya G, Badilli U, Aksu B, Tarimci N. Quality by design case study 1: Design of 5-fluorouracil loaded lipid nanoparticles by the W/O/W double emulsion—Solvent evaporation method. European Journal of Pharmaceutical Sciences. 2016;84:92-102.
87.    Ojaswi G, Divya N, Digna P. Melanoma & its Drug Targets. Research Journal of Pharmacy & Technology. 2016;9(5):562-70.
88.    Lyu L, Huang LQ, Huang T, Xiang W, Yuan JD, Zhang CH. Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis. Drug design, development & therapy. 2018;12:743.
89.    Clemente N, Ferrara B, Gigliotti CL, Boggio E, Capucchio MT, Biasibetti E, Schiffer D, Mellai M, Annovazzi L, Cangemi L, Muntoni E. Solid lipid nanoparticles carrying temozolomide for melanoma treatment. Preliminary in vitro & in vivo studies. International journal of molecular sciences. 2018;19(2):255.
90.    Subash VK, Radha S, Thatikonda S, Rao AY, Prakash CS. Nail toxicity induced by cancer chemotherapy patients: data from the two multispecialty hospital. Research Journal of Pharmacy & Technology. 2015;8(1):20-6.
91.    Justin A, Manisha C, Choephel T, Thomas P, Banerjee S, Mani S. Recent advances in the treatment of Alzheimer’s disease: An Immunotherapeutic approach. Research Journal of Pharmacy & Technology. 2020;13(4):2057-62.
92.    Saminathan C, Venkatesan P, Madhusudhan S. Selection of Better Method for the Preparation of Nanoparticles by Applying Analytic Hierarchy Process. Research Journal of Pharmacy & Technology. 2019;12(11):5320-4.
93.    Bellefroid C, Lechanteur A, Evrard B, Piel G. Lipid gene nanocarriers for the treatment of skin diseases: Current state-of-the-art. European Journal of Pharmaceutics & Biopharmaceutics. 2019;137:95-111.
94.    Dixit RP, Puthli SP. Oral strip technology: overview & future potential. Journal of controlled release. 2009;139(2):94-107.
95.    Ita K. Percutaneous penetration of anticancer agents: Past, present & future. Biomedicine & Pharmacotherapy. 2016;84:1428-39.
96.    Sujatha J, Suriya P, Rajeshkumar S. Biosynthesis & Characterization of silver Nanoparticles by Actinomycetes isolated from Agriculture field & its application on Antimicrobial activity. Research Journal of Pharmacy & Technology. 2017;10(6):1963-8.
97.    Jun-Tae K, Mi-Hee S, Sang-Sik L. Study on effect of Skin Pore using Laser & Microcurrent Treatment. Research Journal of Pharmacy & Technology. 2018;11(11):4862-5.
98.    Hemalatha CN, Kumar YP, An&hi VM. Formulation & Characterization of Nanoparticles Loaded with Cefadroxil. Research Journal of Pharmacy & Technology. 2017;10(1):183-7.
99.    Byrne JD, Yeh JJ, DeSimone JM. Use of iontophoresis for the treatment of cancer. Journal of Controlled Release. 2018;284:144-51.
100.    Mathialagan V, Sugumaran A, Narayanaswamy D. Nanoemulsion: Importance in Pharmaceutical Nanotechnology. Research Journal of Pharmacy & Technology. 2020;13(4):2007-12.
101.    Yang C, Li Y, Du M, Chen Z. Recent advances in ultrasound-triggered therapy. Journal of Drug Targeting. 2019;27(1):33-50.

Recomonded Articles:

Author(s): Rakhi Mehra, Renu Makhija, Neera Vyas

DOI: Not Available         Access: Open Access Read More

Author(s): R. Narayana Charyulu, P. Parvathy Devi, Jobin Jose, A. Veena Shetty

DOI: Not Available         Access: Open Access Read More

Author(s): Ravindranath S. Misal, Vishawas R. Potphode, Vijay R. Mahajan

DOI: 10.5958/0974-360X.2017.00218.9         Access: Open Access Read More

Author(s): Priya P. Munshi, D.S. Mohale, R. Akkalwar, A.V. Chandewar

DOI: Not Available         Access: Open Access Read More

Author(s): Ankit Patel, Pankaj Kushwah, Sujit Pillai, Ajay Raghuvanshi, Nitin Deshmukh

DOI: 10.5958/0974-360X.2017.00013.0         Access: Open Access Read More

Author(s): Niharika, Navneet Verma

DOI: 10.5958/0974-360X.2016.00182.7         Access: Open Access Read More

Author(s): Suha Alnaeb, Youssef Alahmad, Saleh Trefi

DOI: 10.5958/0974-360X.2019.01035.7         Access: Open Access Read More

Author(s): Lakshmi Narasimha, A. Tamil Selvan, D. Jairam, R. Suthakaran

DOI: Not Available         Access: Open Access Read More

Author(s): Kishore Manoharan, Navya Ajitkumar Bhaskaran, Lalit Kumar

DOI: 10.5958/0974-360X.2019.01070.9         Access: Open Access Read More

Author(s): Trilokchandran. B, Vijayakumar G, Thippareddy K S

DOI: 10.5958/0974-360X.2019.00612.7         Access: Open Access Read More

Author(s): Ranjitha Dhevi V. Sundar, Sugashini Settu, Saranya Shankar, Gayathri Segaran, Mythili Sathiavelu

DOI: 10.5958/0974-360X.2018.00153.1         Access: Open Access Read More

Author(s): Sandeep DS, Narayana Charyulu R, Prashant Nayak, Aliss Maharjan, Indira Ghalan

DOI: 10.5958/0974-360X.2016.00163.3         Access: Open Access Read More

Author(s): Sandeep D. S, Prashant Nayak, Jobin Jose, Rishal Relita M, Sumana D. R.

DOI: 10.5958/0974-360X.2017.00317.1         Access: Open Access Read More

Author(s): Pande S. D., Wagh A.S., Bhagure L.B., Patil S.G., Deshmukh A.R.

DOI: 10.5958/0974-360X.2015.00070.0         Access: Open Access Read More

Author(s): J. Rubika

DOI: Not Available         Access: Open Access Read More

Author(s): Sonte Sushmitha, Sedimbi Revathi Priyanka, L. Mohan Krishna, M. Srinavasa Murthy

DOI: Not Available         Access: Open Access Read More

Author(s): S. Subasree, Karthikeyan Murthykumar, Dhanraj

DOI: 10.5958/0974-360X.2016.00116.5         Access: Open Access Read More

Author(s): Rupali Deshmukh, Roshni Agrawal, Sarita Chauragde, Swati Lilhare, M. U. Mishra

DOI: 10.5958/0974-360X.2018.00831.4         Access: Open Access Read More

Author(s): Mythili. L, GNK. Ganesh, C. Monisha, Kayalvizhi. R

DOI: 10.5958/0974-360X.2019.00426.8         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags